Company Filing History:
Years Active: 2024
Title: Chenchen Yang: Innovator in Immunogenic Composition for SARS-COV-2
Introduction
Chenchen Yang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of immunology, particularly in the development of a novel immunogenic composition aimed at combating SARS-COV-2 infection. His work is crucial in the ongoing fight against COVID-19.
Latest Patents
Chenchen Yang holds a patent for an AD35-vectored immunogenic composition for SARS-COV-2 infection. This patent discloses a replication-defective Ad35-vectored immunogenic composition designed to induce an immune response against SARS COV-2. The composition includes an Ad35 vector that encodes the optimized nucleic acid sequence of SEQ ID NO: 1. The disclosed embodiments demonstrate improved safety and convenience of use. Experimental results indicate that this immunogenic composition can produce a higher quantity of S proteins in human cells. Furthermore, it may be utilized in conjunction with other immunogenic compositions or as a therapeutic option for COVID-19. When administered at the initial stage of infection, this composition effectively induces an immune response, achieving a therapeutic effect.
Career Highlights
Chenchen Yang is associated with Guangzhou N Biomed Ltd., where he continues to advance his research and development efforts. His innovative work in immunogenic compositions has positioned him as a key figure in the biotechnology sector.
Collaborations
Chenchen Yang collaborates with talented individuals such as Ling Chen and Suhua Guan, who contribute to his research endeavors. Their combined expertise enhances the potential impact of their work in the field of immunology.
Conclusion
In summary, Chenchen Yang is a pioneering inventor whose work on an AD35-vectored immunogenic composition represents a significant advancement in the fight against SARS-COV-2. His contributions are vital to the ongoing efforts to develop effective therapies for COVID-19.